SSY GROUP(02005): Ammoni Pyridine has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient used in marketed preparations.
ShiSi Medicine Group (02005) released an announcement that the group's Amoxicillin has been approved and registered by the Chinese National Medical Products Administration.
SSY Group (02005) announced that the group's amantadine has been approved and registered by the China National Medical Products Administration as a raw material for use in on-market preparations, making it the first in the country to receive approval. Amantadine is a potassium channel blocker, mainly used to improve walking speed in adults with certain multiple sclerosis.
Related Articles
Jiangsu Yida Chemical (300721.SZ) two shareholders plan to collectively reduce their holdings by 1.1089 million shares.
Hefei Snowky Electric (001387.SZ) plans to acquire a controlling stake in Shengbang Electric, extending its reach to the upstream of the industrial chain.
New stock news | Wolong Electric Group (600580.SH) submits an application to the Hong Kong Stock Exchange, ranking first in the global explosion-proof electric drive system solution market.
Jiangsu Yida Chemical (300721.SZ) two shareholders plan to collectively reduce their holdings by 1.1089 million shares.
Hefei Snowky Electric (001387.SZ) plans to acquire a controlling stake in Shengbang Electric, extending its reach to the upstream of the industrial chain.
New stock news | Wolong Electric Group (600580.SH) submits an application to the Hong Kong Stock Exchange, ranking first in the global explosion-proof electric drive system solution market.
RECOMMEND
Hong Kong Stock Concepts | Boosting Consumption: Dual Interest Subsidy Programs Implemented to Benefit Key Sectors
13/08/2025
Countdown to Evergrande’s Delisting: HK$350 Billion in Liabilities, Only HK$2 Billion Recovered
13/08/2025
U.S. July Tariff Receipts Reach Record High, Yet Budget Deficit Continues to Grow
13/08/2025
